249 related articles for article (PubMed ID: 10428200)
1. Helicobacter pylori infection and risk of gastric cancer in Shanghai, China: updated results based upon a locally developed and validated assay and further follow-up of the cohort.
Yuan JM; Yu MC; Xu WW; Cockburn M; Gao YT; Ross RK
Cancer Epidemiol Biomarkers Prev; 1999 Jul; 8(7):621-4. PubMed ID: 10428200
[TBL] [Abstract][Full Text] [Related]
2. [Helicobacter pylori infection and gastric cardia cancer: a nested case-control study].
Ren JS; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):428-31. PubMed ID: 19024516
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.
Wang T; Cai H; Zheng W; Michel A; Pawlita M; Milne G; Xiang YB; Gao YT; Li HL; Rothman N; Lan Q; Shu XO; Epplein M
Clin Infect Dis; 2017 May; 64(10):1380-1386. PubMed ID: 28402440
[TBL] [Abstract][Full Text] [Related]
4. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan.
Lin JT; Wang LY; Wang JT; Wang TH; Yang CS; Chen CJ
Anticancer Res; 1995; 15(2):603-6. PubMed ID: 7763044
[TBL] [Abstract][Full Text] [Related]
5. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.
Forman D; Newell DG; Fullerton F; Yarnell JW; Stacey AR; Wald N; Sitas F
BMJ; 1991 Jun; 302(6788):1302-5. PubMed ID: 2059685
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men.
Epplein M; Zheng W; Xiang YB; Peek RM; Li H; Correa P; Gao J; Michel A; Pawlita M; Cai Q; Shu XO
Cancer Epidemiol Biomarkers Prev; 2012 Dec; 21(12):2185-92. PubMed ID: 23035179
[TBL] [Abstract][Full Text] [Related]
7. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
[TBL] [Abstract][Full Text] [Related]
8. Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group.
Wong BC; Lam SK; Ching CK; Hu WH; Kwok E; Ho J; Yuen ST; Gao Z; Chen JS; Lai KC; Ong LY; Chen BW; Wang WH; Jiang XW; Hou XH; Lu JY
J Gastroenterol Hepatol; 1999 Feb; 14(2):120-5. PubMed ID: 10029291
[TBL] [Abstract][Full Text] [Related]
9. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects.
Simán JH; Engstrand L; Berglund G; Florén CH; Forsgren A
Clin Diagn Lab Immunol; 2005 Feb; 12(2):304-9. PubMed ID: 15699426
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.
González CA; Megraud F; Buissonniere A; Lujan Barroso L; Agudo A; Duell EJ; Boutron-Ruault MC; Clavel-Chapelon F; Palli D; Krogh V; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Sanchez-Cantalejo E; Navarro C; Barricarte A; Dorronsoro M; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Bas Bueno-de-Mesquita H; Jeurnink SM; Numans ME; Peeters PHM; Lagiou P; Valanou E; Trichopoulou A; Kaaks R; Lukanova-McGregor A; Bergman MM; Boeing H; Manjer J; Lindkvist B; Stenling R; Hallmans G; Mortensen LM; Overvad K; Olsen A; Tjonneland A; Bakken K; Dumeaux V; Lund E; Jenab M; Romieu I; Michaud D; Mouw T; Carneiro F; Fenge C; Riboli E
Ann Oncol; 2012 May; 23(5):1320-1324. PubMed ID: 21917738
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population.
Bernstein CN; McKeown I; Embil JM; Blanchard JF; Dawood M; Kabani A; Kliewer E; Smart G; Coghlan G; MacDonald S; Cook C; Orr P
Dig Dis Sci; 1999 Apr; 44(4):668-74. PubMed ID: 10219820
[TBL] [Abstract][Full Text] [Related]
13. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China.
Webb PM; Yu MC; Forman D; Henderson BE; Newell DG; Yuan JM; Gao YT; Ross RK
Int J Cancer; 1996 Sep; 67(5):603-7. PubMed ID: 8782645
[TBL] [Abstract][Full Text] [Related]
14. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection.
Parsonnet J; Friedman GD; Orentreich N; Vogelman H
Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
[TBL] [Abstract][Full Text] [Related]
16. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
17. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
[TBL] [Abstract][Full Text] [Related]
18. Seroreactivity to 19.5-kDa antigen in combination with absence of seroreactivity to 35-kDa antigen is associated with an increased risk of gastric adenocarcinoma.
Chua TS; Fock KM; Chan YH; Dhamodaran S; Sim CS; Ng TM; Teo EK
Helicobacter; 2002 Aug; 7(4):257-64. PubMed ID: 12165034
[TBL] [Abstract][Full Text] [Related]
19. Recent changes in the prevalence of Helicobacter pylori infection among children and adults in high- or low-incidence regions of gastric cancer in China.
Zhang DH; Zhou LY; Lin SR; Ding SG; Huang YH; Gu F; Zhang L; Li Y; Cui RL; Meng LM; Yan XE; Zhang J
Chin Med J (Engl); 2009 Aug; 122(15):1759-63. PubMed ID: 19781321
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection and the risk of gastric carcinoma.
Parsonnet J; Friedman GD; Vandersteen DP; Chang Y; Vogelman JH; Orentreich N; Sibley RK
N Engl J Med; 1991 Oct; 325(16):1127-31. PubMed ID: 1891020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
